Press Releases

DUBLIN, Oct. 25, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that five new studies of XIAFLEX® (collagenase clostridium histolyticum) for the treatment of Peyronie's disease will be presented as poster presentations at the 20th Annual Fall Meeting of the Sexual Medicine Society of

WARRINGTON, Pa., Oct. 25, 2019 /PRNewswire/ -- Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today provided updates on its lead development programs and business operations.

TARRYTOWN, N.Y., Oct. 25, 2019 /PRNewswire/ -- Regeneron is the most highly ranked company over the past decadeRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the company was once again ranked as a top company to work for by Science magazine in its annual Top Employers Survey of the global biotech and pharm

VANCOUVER, Oct. 25, 2019 /PRNewswire/ - Choom™ (CSE: CHOO; OTCQB: CHOOF) is very pleased to announce the appointment of Corey Gillon as the company's new Chief Executive Officer effective Monday, December 1, 2019, and subject to provincial regulatory approvals. In addition to his executive manag

TARRYTOWN, N.Y., Oct. 25, 2019 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today celebrates its third annual Day for Doing Good, a company-wide global day of service. Reflecting Regeneron's long-standing commitment to its local communities and culture of volunteerism, thousands of company employees are participating in volunteer activitie

DUBLIN, Oct. 25, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that its Board of Directors has declared a cash dividend of $0.74 per ordinary share for the fourth quarter of 2019. The dividend will be paid on December 13, 2019 to shareholders of record at the close of business on November 13,

SAN JOSE, Calif., Oct. 25, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against canc

KING OF PRUSSIA, Pa., Oct. 25, 2019 /PRNewswire/ -- Recovery Centers of America ("RCA") announced an open application period for students seeking to apply for the

KING OF PRUSSIA, Pa., Oct. 25, 2019 /PRNewswire/ -- Universal Health Realty Income Trust (NYSE:UHT) announced today that for the three-month period ended September 30, 2019, reported net income was $4.7 million, or $.34 per diluted share, as compared to $4.4 million, or

SOUTH SAN FRANCISCO, Calif., Oct. 25, 2019 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics, announced that the company is scheduled to present in the following investor conferences: